What is Seaport Therapeutics 's cash & equivalents?

Seaport Therapeutics (SPTX) reported cash & equivalents of $52.91M in Q1 2026.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Seaport Therapeutics SPTX Cash & Equivalents

Cash & Equivalents at other companies

MYR GroupMYRG

$163.19M+1,398%

RepligenRGEN

$582.65M-16.4%

NNN REITNNN

$4.57M-10.3%

Piper SandlerPIPR

$344.43M+173%

Sensata TechnologiesST

$635.1M+8.0%

AppFolioAPPF

$147.66M+158%

Other financials

Income statement

See full

Operating income-$27.5M-70.2%

Net income-$25.4M-93.6%

EPS (diluted)-$10.34-83.0%

Balance sheet

See full

Total debt$5.3M—

Total equity-$115.6M-220%

Total assets$227.7M—

Cash flow

See full

Operating cash flow-$20.2M+0.2%

CapEx--100%

Free cash flow-$20.2M+0.4%

Valuation

See full

Market cap$972.65M—

Enterprise value$925.08M—

Returns & leverage

See full

Debt / equity-0×—

Current ratio13.2×—

Where this comes from

Reported directly by Seaport Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Seaport Therapeutics ’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Seaport Therapeutics 's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Seaport Therapeutics 's cash & equivalents?: Seaport Therapeutics (SPTX) reported cash & equivalents of $52.91M in Q1 2026.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.